When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOLD - Amicus up 2% premarket on positive data on Batten disease gene therapy
Amicus Therapeutics Inc.
Amicus Therapeutics (NASDAQ:FOLD) perks up 2% premarket on light volume in response to encouraging preliminary data from a Phase 1/2 clinical trial evaluating its AAV-CLN6 gene therapy in patients with a rare inherited nervous system disorder called CLN6 Batten disease.
More news on: Amicus Therapeutics, Inc., Healthcare stocks news, Stocks on the move,